http://www.onclive.com/onclive-tv/dr-van-cutsem-on-regorafenib-for-patients-with-colorectal-cancer
Dr. Van Cutsem on Regorafenib for Patients With Colorectal Cancer

Eric Van Cutsem, MD, PhD


Eric Van Cutsem, MD, PhD, of University Hospitals Gasthuisberg/Leuven, Leuven, Belgium, discusses regorafenib (Stivarga) as a treatment for patients with colorectal cancer (CRC).
Printer Printing...